GB201001950D0 - Infection prognostic assay - Google Patents

Infection prognostic assay

Info

Publication number
GB201001950D0
GB201001950D0 GBGB1001950.3A GB201001950A GB201001950D0 GB 201001950 D0 GB201001950 D0 GB 201001950D0 GB 201001950 A GB201001950 A GB 201001950A GB 201001950 D0 GB201001950 D0 GB 201001950D0
Authority
GB
United Kingdom
Prior art keywords
cancer
subject
infection
prognostic assay
flc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1001950.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Binding Site Group Ltd
Original Assignee
Binding Site Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Binding Site Group Ltd filed Critical Binding Site Group Ltd
Priority to GBGB1001950.3A priority Critical patent/GB201001950D0/en
Publication of GB201001950D0 publication Critical patent/GB201001950D0/en
Priority to JP2012551689A priority patent/JP5818818B2/ja
Priority to JP2012551687A priority patent/JP5818817B2/ja
Priority to EP11702698.9A priority patent/EP2531857B1/en
Priority to US13/576,099 priority patent/US20130217030A1/en
Priority to US13/576,063 priority patent/US20130149792A1/en
Priority to CN201180008422.8A priority patent/CN102859362B/zh
Priority to CN201180008402.0A priority patent/CN102859361B/zh
Priority to PCT/GB2011/050197 priority patent/WO2011095820A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB1001950.3A 2010-02-05 2010-02-05 Infection prognostic assay Ceased GB201001950D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB1001950.3A GB201001950D0 (en) 2010-02-05 2010-02-05 Infection prognostic assay
JP2012551689A JP5818818B2 (ja) 2010-02-05 2011-02-04 感染症予後診断アッセイ
JP2012551687A JP5818817B2 (ja) 2010-02-05 2011-02-04 がん予後診断アッセイ
EP11702698.9A EP2531857B1 (en) 2010-02-05 2011-02-04 Infection prognostic assay
US13/576,099 US20130217030A1 (en) 2010-02-05 2011-02-04 Infection prognostic assay
US13/576,063 US20130149792A1 (en) 2010-02-05 2011-02-04 Cancer prognosis assay
CN201180008422.8A CN102859362B (zh) 2010-02-05 2011-02-04 感染预后分析
CN201180008402.0A CN102859361B (zh) 2010-02-05 2011-02-04 癌症预后分析
PCT/GB2011/050197 WO2011095820A1 (en) 2010-02-05 2011-02-04 Infection prognostic assay

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1001950.3A GB201001950D0 (en) 2010-02-05 2010-02-05 Infection prognostic assay

Publications (1)

Publication Number Publication Date
GB201001950D0 true GB201001950D0 (en) 2010-03-24

Family

ID=42082582

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1001950.3A Ceased GB201001950D0 (en) 2010-02-05 2010-02-05 Infection prognostic assay

Country Status (6)

Country Link
US (2) US20130217030A1 (enExample)
EP (1) EP2531857B1 (enExample)
JP (2) JP5818817B2 (enExample)
CN (2) CN102859361B (enExample)
GB (1) GB201001950D0 (enExample)
WO (1) WO2011095820A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2519564A (en) * 2013-10-24 2015-04-29 Shared Band Ltd Multicast transmission over bonded broadband
WO2016016897A1 (en) * 2014-07-30 2016-02-04 Smadar Avigad Prognostic methods and systems of treatment for acute lymphoblastic leukemia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4792529A (en) * 1985-10-18 1988-12-20 University Of Rochester Immunoassay of free kappa light chains for the detection of multiple sclerosis
IT1216698B (it) * 1988-04-01 1990-03-08 New Scient Co Spa Metodo per la determinazione della presenza di catene leggere libere in campioni di urina, complesso di preparati per l'esecuzione del metodo, e relativo reagente.
EP0862584B1 (en) 1995-11-03 2004-12-22 The Binding Site Limited Production of antibodies
US6322788B1 (en) * 1998-08-20 2001-11-27 Stanley Arthur Kim Anti-bacterial antibodies and methods of use
US20040018576A1 (en) * 2002-07-24 2004-01-29 Dematteo Todd M. Bence Jones protein testing cassette
JP4438455B2 (ja) * 2004-03-04 2010-03-24 ヤマサ醤油株式会社 遊離ヒトイムノグロブリン軽鎖の測定法及びキット
WO2005116651A2 (en) * 2004-05-24 2005-12-08 Diasys Corporation Method and device for testing for bence-jones protein
AU2005304320A1 (en) * 2004-11-12 2006-05-18 Board Of Regents, The University Of Texas System Methods of treating hematological malignancies with nucleoside analog drugs
GB0501741D0 (en) * 2005-01-27 2005-03-02 Binding Site The Ltd Antibody
EP2267449B1 (en) * 2005-04-12 2014-01-08 Akira Matsumori Biomarker for diagnosing heart failure and the use thereof
JP2007292661A (ja) * 2006-04-26 2007-11-08 Akira Matsumori 活動性心筋炎の検出方法および検出試薬
GB0801609D0 (en) * 2008-01-29 2008-03-05 Binding Site The Ltd Hevylite diagnostic stain

Also Published As

Publication number Publication date
CN102859362B (zh) 2015-11-25
JP2013519083A (ja) 2013-05-23
EP2531857B1 (en) 2017-01-18
JP2013519082A (ja) 2013-05-23
US20130149792A1 (en) 2013-06-13
JP5818818B2 (ja) 2015-11-18
US20130217030A1 (en) 2013-08-22
CN102859361B (zh) 2015-06-17
JP5818817B2 (ja) 2015-11-18
EP2531857A1 (en) 2012-12-12
CN102859361A (zh) 2013-01-02
WO2011095820A1 (en) 2011-08-11
CN102859362A (zh) 2013-01-02

Similar Documents

Publication Publication Date Title
TN2013000358A1 (en) Fgfr and ligands thereof as biomarkers for breast cancer in hr positive subjects
IN2013CN01129A (enExample)
BR112013006683A2 (pt) diagnóstico de câncer de mama
WO2012021887A3 (en) Biomarkers for the early detection of breast cancer
WO2010096154A3 (en) Compositions and methods for diagnosis and prognosis of colorectal cancer
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
MX341517B (es) Biomarcadores de cancer pancreatico y usos de los mismos.
ES2570380T3 (es) Método para determinar la aptitud de inhibidores de EZH2 humano en tratamiento
EA201390762A1 (ru) Новые биомаркеры для предсказания исхода противораковой иммунотерапии
MY159553A (en) Detection and treatment of pancreatic, ovarian and other cancers
IN2015DN01855A (enExample)
TR201907389T4 (tr) Meme kanserinden kaynaklanan metastazlı kemik kanserinin prognozu ve tedavisine yönelik yöntem.
EA201400117A1 (ru) Способы и нуклеиновые кислоты для определения прогноза у больных раком
IL233098A (en) Cancer Detection and Prognosis Methods and Survival Probabilities and Biomarkers Based on Their Use
TN2013000464A1 (en) Biomarkers for hedgehog inhibitor therapy
WO2011021041A3 (en) Survival prognostic assay
EP4495266A3 (en) Esophageal cancer detection kit or device, and detection method
MX358541B (es) Metodos para predecir el riesgo de desarrollar hipertension.
CA3210980C (en) Stomach cancer detection kit or device, and detection method
EA201370063A1 (ru) Фосфолипидом рака
AR105618A1 (es) Metilación del promotor del ligando al receptor de muerte programada (pd-l1) en cáncer
CO6311041A2 (es) Un metodo para determinar y monitorear un cancer ginecologico que comprende la determinacion de niveles de biomarcadores en una muestra biologica
MX2013011431A (es) Metodos para predecir y mejorar la supervivencia de pacientes con cancer gastrico.
SG10201806729VA (en) Novel assay to detect human periostin
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)